EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metastatic Unfunctional Pancreatic Neuroendocrine Tumor in Lynch Syndrome

Fateme Salemi iD, Zahra Sadin iD, Atefe Barzegari, Seyed Mohammad Reza Mortazavizadeh, Massih Bahar, Motahare Amiri

Clinical Case Reports · 2026-07 · 14 (7)

DOI: 10.1002/ccr3.73036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 29.06.2026. Verfasst von Fateme Salemi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy Tehran University of…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome (LS), a well‐known cancer risk syndrome, is caused by deleterious germline mutations in the mismatch repair genes. LS predispose patients to various types of cancers including colon adenocarcinoma. We discuss the case of a woman with LS who also developed a non‐functioning pancreatic neuroendocrine tumor (P‐NET) following primary colon adenocarcinoma. Multiple liver lesions were discovered 6 months following surgical excision the pancreatic mass and were later determined to be a neuroendocrine tumor. Liver lesions shrank after treatment with octreotide and Lutetium‐177 vipivotide tetraxetan. She is in remission and takes positron emission tomography scans every 6 months for monitoring. This case highlights the importance of LS genetic testing, the function of microsatellite instability (MSI) as a screening marker, and the need for additional study on the relationship between LS and P‐NETs, particularly through advanced molecular testing to confirm lesion relationships. The role of microsatellite instability (MSI) as a screening marker, and personalized treatment approaches like immunotherapy for dMMR tumors. Understanding these correlations may assist in early discovery, surveillance, and customized treatment for patients dealing with LS‐associated malignancies.

Schlagwörter

Stichwörter der Autor:innen

Lynch syndromeMutL homolog‐ 1dMMRpancreatic neuroendocrine tumor

Autor:innen und Institutionen

  • Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy Tehran University of Medical Sciences Tehran Iran.
  • Department of Stem Cells and Developmental Biology Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR Tehran Iran.
  • Department of Hematology and Oncology Islamic Azad University, Yazd Branch Yazd Iran.
  • Department of Clinical Biochemistry Tehran University of Medical Sciences, Faculty of Medicine Tehran Iran.
  • Department of Operative Dentistry, School of Dentistry Shahid Sadoughi University of Medical Sciences Yazd Iran.

ORCID-Profile: Fateme Salemi, Zahra Sadin

Zitieren

APA

Salemi, F., Sadin, Z., Barzegari, A., Mortazavizadeh, S. M. R., Bahar, M., & Amiri, M. (2026). Metastatic Unfunctional Pancreatic Neuroendocrine Tumor in Lynch Syndrome. Clinical Case Reports, 14(7). https://doi.org/10.1002/ccr3.73036

Vancouver

Salemi F, Sadin Z, Barzegari A, Mortazavizadeh SMR, Bahar M, Amiri M. Metastatic Unfunctional Pancreatic Neuroendocrine Tumor in Lynch Syndrome. Clinical Case Reports. 2026;14(7). doi:10.1002/ccr3.73036

BibTeX
@article{Salemi2026,
  author = {Salemi, Fateme and Sadin, Zahra and Barzegari, Atefe and Mortazavizadeh, Seyed Mohammad Reza and Bahar, Massih and Amiri, Motahare},
  title = {Metastatic Unfunctional Pancreatic Neuroendocrine Tumor in Lynch Syndrome},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {7},
  doi = {10.1002/ccr3.73036}
}
Kostenlos starten →